Net Loss per Common Share (Details 1) - shares	1 Months Ended	3 Months Ended	9 Months Ended
Oct. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net Loss per Common Share
Option and RSUs to purchase common stock	533,332	4,943,284	657,998	4,943,284	657,998
Warrants to purchase common stock		3,323,654	966,174	3,323,654	966,174
Convertible note to purchase common stock		6,401,343	138,581	6,401,343	138,581
Total potential shares		14,668,281	1,762,753	14,668,281	1,762,753

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration